Patient-Focused Drug Development: Incorporating Clinical Outcome Assessments Into Endpoints for Regulatory Decision-Making; Draft Guidance for Industry, Food and Drug Administration Staff, and Other Stakeholders; Availability

1 organizations filed 1 public comment on Patient-Focused Drug Development: Incorporating Clinical Outcome Assessments Into Endpoints for Regulatory Decision-Making; Draft Guidance for Industry, Food and Drug Administration Staff, and Other Stakeholders; Availability, at the Food and Drug Administration. The comment window closed 1119d ago.

Abstract

Open

Commenters (1)

• Advanced Medical Technology Associationtrade assoc.

  1 filing · confidence 97%